iRhythm Technologies (San Francisco, CA), a commercial-stage medical device company that focused on cardiac rhythm monitoring, closed a $1.5M Series C financing. Participants include the California HealthCare Foundation.

Synovex (Boston, MA), a clinical stage biotechnology company focused on inhibiting the progression of fibrotic diseases such as arthritis, closed a $3.5M Series C financing. Participants were not identified.

Intarcia Therapeutics (Hayward, CA), a clinical stage medical device company focused on developing a subcutaneous device to continuously deliver diabetes therapeutic exenatide, closed a $160M Series C financing, in addition to a $50M debt financing, totaling $210M for the round. Participants include New Enterprise Associates, New Leaf Venture Partners, Venrock, The Baupost Group, and Farallon [...]

NanoBio (Ann Arbor, MI), a clinical-stage biotechnology company focused on anti-infective intranasal & intramuscular vaccines for influenza, closed an $11M Series C financing. Participants include Perseus and Venture Investors.

GlySure (United Kingdom), a clinical-stage medical device company focused on continuous blood glucose monitoring, closed a $13.6M Series C financing. Participants include Amadeus Capital Partners, Chester Investments, Delta Partners and Morningside Ventures.

Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital, Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

TxCell (France), a clinical-stage biotechnology developing cell-based immunotherapies for chronic inflammatory and neurological diseases, closed a $15.9M Series C financing. Participants include CDC Entreprises, Auriga Partners and Seventure Partners. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive Collective IP [...]

Sensimed (Switzerland), a commercial-stage medical device company focused on glaucoma-monitoring, closed a $22M Series C financing. Participants include Wellington Partners, Agate Medical Investments, Vinci Capital/Renaissance PME, Sandoz Family Foundation and ELM Development. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive [...]

Genocea Biosciences (Cambridge, MA), a clinical-stage biotechnology company focused on therapeutic and prophylactic vaccines for infectious diseases, closed a $30M Series C financing. Participants include Bill & Melinda Gates Foundation, Central Valley Fund, Johnson & Johnson Development Corp., Skyline Ventures, MP Healthcare Venture Management, Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga [...]

Hemoshear (Charlottesville, VA), a biotechnology company focused on the development of human and animal cell-based systems for discovery and assessment of drug compounds, closed a $4M Series C financing. Participants were not identified. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem Request [...]

ZS Pharma (Forth Worth, TX), a clinical-stage pharmaceutical company focused on the development of therapies to treat kidney and liver disease, closed a $46M Series C. Participants include Alta Partners, RiverVest Venture Partners, 3×5 Special Opportunity Partners, Salem Partners and Devon Park Bioventures. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and [...]

Thrasos Therapeutics (Canada), a clinical-stage pharma company focused on acute kidney injury, closed a $35M Series C financing. Participants include SR One, GSK Canada Life Sciences Innovation Fund, Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management and Pappas Ventures. ___________ Collective IP | The Most Comprehensive and Accurate View of [...]

Spinal Restoration (Austin, TX), a clinical stage biotechnology company focused on the treatment of discogenic chronic low back pain, closed a $5M Series C financing. Participants include Austin Ventures, Santé Ventures, MB Venture Partners and Comerica Bank. ___________ Collective IP the Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer [...]